The serological activities of the specific phenolic glycolipid I from Mycobacterium leprae, its dissected parts, and related glycolipids from other mycobacteria were examined by enzyme-linked immunosorbent assay against hyperimmune anti-M. leprae rabbit antiserum and sera from patients with leprosy and other mycobacterial diseases. High anti-phenolic glycolipid I immunoglobulin M antibodies were found in 23 of 24 (96%) of lepromatous leprosy patients on short term chemotherapy and in 8 of 13 tuberculoid leprosy patients (62%). Sera from patients with tuberculosis or atypical mycobacterial infections were devoid of anti-phenolic glycolipid I activity. The structurally related phenolic glycolipids from Mycobacterium kansasii and Mycobacterium bovis and the aglycone segments of the M. leprae product showed no significant activity. Thus, the trisaccharide determinant of phenolic glycolipid I is specific in its structure, serological activity, and, to a lesser extent, the antibody class it evokes.
The recent isolation of a number of unique phthiocerol-containing lipids from the surface of Mycobacterium leprae (9, 10) affords the unprecedented opportunity to relate specific, fully defined, leprosy bacillary moieties to the immunological responses of leprosy patients. Since these lipids comprise the bulk of the copious outer bacillary extensions (9) , they may represent the primary functional interface between the organism and the host's defense. The principal lipid is a diacylphthiocerol (9) , but the more interesting are three triglycosylphenolic diacylphthiocerols, two of which have been fully characterized and shown to contain the previously unrecognized trisaccharide appendages: 3,6 -di -0 -methyl -, -D -glucopyranosyl(1--4) 2,3-di-0-methyl-a-L-rhamnopyranosyl(1--*2) 3-0-methyl-a-L-rhamnopyranose (in phenolic glycolipid I [Phen GL-I]) and 6-O-methyl-P-Dglucopyranosyl(1-*4)2,3-di-0-methyl-a-L-rhamnopyranosyl(l-*2)3-0-methyl-a-L-rhamnopyranose (in phenolic glycolipid III) (9, 10) . Since the trisaccharides hold the promise of the longsought M. leprae-specific antigen determinants, immediate interest concerns the potential of these trisaccharides for the specific serodiagnosis of leprosy. To this end, the activities of the native phenolic glycolipid I and its dissected components were examined against anti-M. leprae rabbit antiserum and sera from leprosy patients across the clinicohistopathological spectrum of the disease. In addition, the activity of a closely related triglycosylphenolic diacylphthiocerol from Mycobacterium kansasii and that of sera from patients with mycobacterial infections other than leprosy were examined to better delineate the specificity of the glycolipid antigen for serological assessment of leprosy.
MATERIALS AND METHODS
Source of lipids. Lipids were obtained by extraction of M. leprae-infected'armadillo tissues and fractionated on silicic acid columns (10) . Dimycocerosyl phthiocerol was eluted with CHC13 and purified by preparative thin-layer chromatography (TLC) in CHC13 (9) . Phthiocerol was derived from it by alkalinolysis and fully purified by preparative TLC (9) . Phen GL-I was obtained by further irrigation of silicic acid columns with 2% CH30H in CHC13, followed by preparative TLC in ether-acetone (8:2) (10). Deacylated Phen GL-I and its fatty acids were derived from the native glycolipid by alkalinolysis followed by separation of the component parts on silicic acid (10) . The deglycosylated phenolic phthiocerol core was derived from the deacylated Phen GL-I by methanolysis (10) . Preparation and characterization of the triglycosylphenolic diacylphthiocerol (mycoside A) from M. kansasii has been described (8) . The monoglycosylphenolic diacylphthiocerol (mycoside B) of M. bovis was extracted from lyophilized BCG with CHC13-CH30H (2:1), and partially purified by elution from silicic acid columns with CHCl3-1% methanol in CHCl3. Final purification was accomplished by preparative TLC in diethyl ether-acetone (9:1). The structure was examined by procedures described previously (9, 10) , and that reported by Demarteau-Ginsburg and Lederer (5) ELISA conditions. For enzyme-linked immunosorbent assay (ELISA) analysis of human sera, lipids (100 .g/ml) were suspended in carbonate-bicarbonate coating buffer (pH 9.6; reference 16) by direct sonication for 20 to 30 s with a 3-mm probe. The suspension was diluted to the required concentration with the same buffer; 50 ,ul was added to wells of polystyrene microtiter plates which were incubated at 37°C for 14 to 16 h in a moist chamber. Wells were washed with phosphate-buffered saline (PBS), blocked by the addition of 100 ,ul of PBS containing 5% bovine serum albumin (BSA), and incubated at 37°C for 1 h in a moist chamber. The contents were aspirated, and 50 ,ul of human serum diluted with PBS containing 20%o normal goat serum (PBS-NGS) was added. Plates were incubated at 37°C for 1 h, washed with PBS, followed by the addition of goat.anti-human immunoglobulin M (IgM)-or immunoglobulin G (IgG)-peroxidase conjugate reagent (Cappel Laboratories, Downington, Pa.) diluted 1/1,000 in PBS-NGS. After a 1-h incubation and five further washings, 50 ,ul of H202-O-phenylenediamine substrate-dye reagent in citrate phosphate buffer (16) were added and incubated at 37°C for 30 min in the case of the IgM conjugate and 2 h for the IgG conjugate. Reactions were terminated with 2.5 N H2SO4 after a 30-min incubation and the absorbance was read at 488 nm (A488). ELISA was also conducted with whole M. leprae suspended in coating buffer (50 jig/ml). ELISA on hyperimmune rabbit serum was conducted as described (10) . To abolish IgM activity, reduction with 2-mercaptoethanol was performed as described by Melsom and Duncan (12) . IgG was separated from IgM with a commercial IgM isolation kit (Isolab Inc., Akron, Ohio) based on the procedure described by Johnson and Libby (11) .
Statistics. Statistical analysis was performed by using the group comparison Student t test. RESULTS Development of ELISA. The ELISA conditions described previously using hyperimmune anti-M. leprae antiserum were suitable for demonstrating the inherent serological activity of native Phen GL-I, but the few human sera tested were marked by abnormally high background absorbances (10) . In another set of conditions, in which ethanol was employed as the coating medium and PBS-Tween was used for nonspecific blocking and as the diluent, intact Phen GL-I reacted poorly, and deacylated Phen GL-I did not react at all; presumably, it did not adsorb and was lost as the fluid phase.
Variation of the conditions basically designed for protein antigens (7, 16) proved to be the most reproducible for Phen GL-I. The important features of the procedure seem to be thorough sonication of the glycolipid in the coating buffer, deletion of detergents from all subsequent steps, use of a double block with heterologous BSA and homologous NGS, and also use of the latter as a diluent. Figure 1 shows the activity observed with the pooled human lepromatous leprosy sera and a range of glycolipid concentrations with either the IgM-or IgG-conjugated reagent. IgM responses were uniformly much higher than those of IgG. When pooled sera from lepromatous leprosy patients were reduced with 2-mercaptoethanol all anti-Phen GL-I IgM activity was abolished, and only the low residual IgG activity remained. When the majority of IgG subclasses were removed from IgM by aminoethyl-Sephedex A-50 ion-exchange chromatography (11), there was little diminution in activity; the correlation coefficient between the A488 values for purified IgM and for whole serum IgM was 0.992. Thus, the reactive immunoglobulin class is mostly IgM. The lower limit of antigen reactivity was about 250 ng/ml, i.e., 12.5 ng or 6 pmol per well. Antibody titration of the pooled active sera showed an approximate linear relationship between absorption and dilution of serum pool in the range 1:100 to 1:6,400. Based on several trial experiments with pooled active and negative sera, a dilution of 1:300 was chosen, and plates were routinely coated with 2 ,ug of Phen GL-I per ml of buffer (100 ng per well) at 37°C for 14 to and acidic degradations (9, 10) (Fig. 2) . Removal of the fatty acyl functions from Phen GL-I did little to enhance activity (Fig. 3) . Little serological activity was found in the aglycone segments of the phthiocerol-containing lipids, such as the phenolic phthiocerol core, phthiocerol itself, the dimycocerosylphthiocerol or the free mycocerosic acids. Moreover, the monoglycosylphenolic dimycocerosylphthiocerol from M. bovis and the triglycosylphenolic diacylphthiocerol from M. kansasii were devoid of significant activity against the anti-M. leprae rabbit antibodies or those from human lepromatous leprosy patients.
To further examine the serological specificity of the triglycosyl entity, anti-M. leprae rabbit antiserum was reacted against the full range of 31 mycoside C glycopeptidolipid antigens from members of the M. avium-M. intracellulare-M. scrofulaceum serocomplex (2, 4). These glycolipids are endowed with short type-specific tetra-or trisaccharide antigen determinants, are also rich in O-methyl-6-deoxyhexoses and 0-Phenolic Glycoipid-I Fig. 4 ). Even in this latter group the mean A488 value was significantly higher (P < 0.01) than in the healthy subjects.
One of the two borderline patients studied had elevated IgM antibodies (A488, 0.315), but the other did not (A488, 0.065) ( Table 1 and Fig. 5 ). Of the 13 tuberculoid patients studied, 8 (62%) had significant elevations of IgM antibody to Phen GL-I (mean A488, 0.186 ± 0.251); the mean value for tuberculoid patients was significantly 
DISCUSSION
Since their isolation and recognition of their structural uniqueness, the trisaccharide appendages of the phenolic glycolipids had promised to be specific M. leprae haptens, especially when considered in light of the mycoside C polar glycopeptidolipids (2, 4) and the trehalosecontaining lipooligosaccharides (S. W. Hunter, R. C. Murphy, K. Clay, M. B. Goren, and P. J. Brennan, J. Biol. Chem., in press), all highly antigenic and endowed with short oligosaccharides of exquisite specificity. However, unlike these others, the phenolic glycolipids are highly apolar and not readily amenable to serological manipulations. Nevertheless, their potential as tools for the serodiagnosis of leprosy was inferred from initial recognition of them as the likely serologically active components in crude bacillary extracts (3) , and, subsequently, Payne et al. (13) incorporated pure Phen GL-I into liposomes and demonstrated reactivity with sera from lepromatous leprosy patients by gel diffusion. Previously, using hyperimmune anti-M. leprae antiserum, we recognized the felicity of ELISA and assumed that the orientation of the lipid on the polystyrene substratum was such as to render the diacylphthiocerol cryptic and preferentially expose the trisaccharide moiety (10). As described here, ELISA combined with the simple ploy of thorough sonication of the glycolipid in an aqueous medium allows ready reaction between glycolipid and antibodies in sera from leprosy patients. The most gratifying aspect of the present study is the absence of significant binding between the so-called mycoside A of M. kansasii and anti-Phen GL-I antibodies. Previously, we had used mycoside A as an aid to establishing the triglycosylated nature of the product from M. leprae (8) . Although the sugar composition of mycoside A is known (5), the sequence has not been fully established. Nevertheless, there are striking similarities in the two products; both contain trisaccharides, the nonreducing terminus of both is di-O-methylated, there is a preponderance of 0-methyl-6-deoxyhexoses, and there are similarities in the configurations of the anomeric protons. Accordingly, future emphasis must be on the [3,6- (12, 15) . Thus, the anti-M. leprae IgM antibodies may be mostly in response to the specific phenolic glycolipids, whereas IgG may be directed primarily against the more common mycobacterial cell wall antigens, such as the arabinogalactan-peptidoglycan complex (1). Indeed, sera from patients with other mycobacterial infections, although devoid of anti-Phen GL-I antibodies, showed high antiwhole M. leprae IgG. Anti-M. leprae IgM has been attributed to persistent infection (15) . However, it is also possible that IgM might be a bystander response to the glycolipid, driven by nonspecifically acting lymphokines produced by a specifically activated T cell (6) . Thus, the absence of a direct cell-to-cell signal delivered by the T cell to the responding B cell could be the reason for the lack of a substantial IgM-to IgG switch.
Chemotherapy of leprosy has been associated with decreasing antibody titers, whereas relapsed tuberculoid patients generate higher antibody levels (17). Touw et al. have indicated that at the tuberculoid end of the spectrum, solidphase antibodies to whole M. leprae correlated with severity of disease (15) . A specific assay for IgM activity to the specific M. leprae glycolipid, particularly in the preclinical state of the lepromatous form of the disease, may enable earlier chemotherapy and thereby prevent deformity and eliminate the infectious reservoir. 
